Krilogy Financial LLC Acquires Shares of 61,107 SPDR S&P Biotech ETF $XBI

Krilogy Financial LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 61,107 shares of the exchange traded fund’s stock, valued at approximately $7,813,000. Krilogy Financial LLC owned 0.09% of SPDR S&P Biotech ETF as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. JPMorgan Chase & Co. grew its holdings in SPDR S&P Biotech ETF by 27.3% during the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after acquiring an additional 2,900,633 shares during the period. Assetmark Inc. lifted its holdings in SPDR S&P Biotech ETF by 1,042,265.6% in the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after acquiring an additional 635,782 shares during the period. Greenwoods Asset Management Hong Kong Ltd. purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $55,613,000. Ameriprise Financial Inc. boosted its position in SPDR S&P Biotech ETF by 123.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares in the last quarter. Finally, Meitav Investment House Ltd. grew its stake in shares of SPDR S&P Biotech ETF by 70.3% during the 3rd quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock worth $68,156,000 after purchasing an additional 281,602 shares during the period.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $138.67 on Monday. The firm has a market cap of $9.15 billion, a price-to-earnings ratio of 11.47 and a beta of 0.88. The company has a 50 day moving average price of $126.35 and a 200-day moving average price of $121.02. SPDR S&P Biotech ETF has a 1-year low of $74.67 and a 1-year high of $139.19.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.